enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. A.P. Pharma Receives FDA Complete Response Letter for APF530

    www.aol.com/news/2013-03-28-ap-pharma-receives...

    A.P. Pharma Receives FDA Complete Response Letter for APF530 - Company Revises Projected Launch Timing from 2H 2013 to 1H 2014 - - Conference Call to Be Held at 8:30 a.m. Eastern Time - REDWOOD ...

  3. A.P. Pharma Appoints New Management Team - AOL

    www.aol.com/news/2013-05-02-ap-pharma-appoints...

    REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced that its Board of Directors has appointed a new management team to ...

  4. Pacific Shores Center - Wikipedia

    en.wikipedia.org/wiki/Pacific_Shores_Center

    Address: 1700 Seaport Blvd, Redwood City, CA 94063 ... After many years of planning Redwood City and the partnership had a complete ... Threshold Pharmaceutical ...

  5. Abraxis BioScience - Wikipedia

    en.wikipedia.org/wiki/Abraxis_BioScience

    Abraxis was incorporated in 2001 in Los Angeles. [1] It was formerly known as American Pharmaceutical Partners (APP), which as known for its injectable oncology, anti-infective and critical care. [7] Besides cancer treatments, it provided treatment for multiple sclerosis, Alzheimer's, and some cardiovascular diseases. [1]

  6. A.P. Pharma Announces First Quarter 2013 Financial Results ...

    www.aol.com/news/2013-05-10-ap-pharma-announces...

    A.P. Pharma Announces First Quarter 2013 Financial Resultsand Highlights Recent Corporate Progress REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty ...

  7. Adverum Biotechnologies - Wikipedia

    en.wikipedia.org/wiki/Adverum_Biotechnologies

    Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, [2] is a publicly traded [3] clinical stage gene therapy company located in Redwood City, California. [4] The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD).

  8. A.P. Pharma Announces Fourth Quarter and Full Year 2012 ... - AOL

    www.aol.com/news/2013-03-01-ap-pharma-announces...

    A.P. Pharma Announces Fourth Quarter and Full Year 2012 Financial Results and Highlights Recent Corporate Progress REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a ...

  9. Puma Biotechnology - Wikipedia

    en.wikipedia.org/wiki/Puma_Biotechnology

    Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. [2] This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. [2]